Accéder au contenu
Merck

44208

L-Lysine hydrochloride solution

100 mM amino acid in 0.1 M HCl, analytical standard

Se connecter pour consulter les tarifs organisationnels et contractuels.

Sélectionner une taille de conditionnement

Toutes les photos(1)

About This Item

Formule empirique (notation de Hill) :
C6H14N2O2 · HCl
Numéro CAS:
10098-89-2
Poids moléculaire :
182.65
UNSPSC Code:
85151701
NACRES:
NA.24
PubChem Substance ID:
329756466
MDL number:
MFCD00064564
Beilstein/REAXYS Number:
5460909

Nom du produit

L-Lysine hydrochloride solution, 100 mM amino acid in 0.1 M HCl, analytical standard

InChI

1S/C6H14N2O2.ClH/c7-4-2-1-3-5(8)6(9)10;/h5H,1-4,7-8H2,(H,9,10);1H/t5-;/m0./s1

SMILES string

Cl.NCCCC[C@H](N)C(O)=O

InChI key

BVHLGVCQOALMSV-JEDNCBNOSA-N

grade

analytical standard

form

liquid

analyte chemical class(es)

amino acids, peptides, proteins

concentration

100 mM amino acid in 0.1 M HCl

technique(s)

HPLC: suitable
gas chromatography (GC): suitable

color

colorless

application(s)

food and beverages

format

single component solution

storage temp.

2-8°C

Quality Level

100

Catégories apparentées

General description

L-Lysine hydrochloride is one of the essential amino acids which usually finds applications in the treatment of shingles and genital as well mouth lesions attributed to herpes zoster and herpes simplex virus, respectively.

Application

L-Lysine hydrochloride may be used as a reference standard for the determination of L-lysine hydrochloride in pharmaceutical dosage form by high resolution high performance liquid chromatography (HR-HPLC). It may be used as a precursor of lysine for its determination in breath condensate by isotope dilution hydrophilic-interaction liquid chromatography combined with tandem mass spectrometry (HILIC-MS/MS).
Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

pictograms

Corrosion
GHS05

signalword

Warning

hcodes

H290

Hazard Classifications

Met. Corr. 1

Classe de stockage

8B - Non-combustible, corrosive hazardous materials

wgk

nwg

ppe

Eyeshields, Gloves

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number
BCCK1676
BCCJ9113
BCCF4761
BCBZ5132
BCBR4854V

Vous ne trouvez pas la bonne version ?

Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

Rechercher un(e) COA

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Simultaneous determination of the advanced glycation end product Nε-carboxymethyllysine and its precursor, lysine, in exhaled breath condensate using isotope-dilution-hydrophilic-interaction liquid chromatography coupled to tandem mass spectrometry
Schettgen T, et al.
Analytical and Bioanalytical Chemistry, 387(8), 2783-2791 (2007)
Development and validation of new hplc method for simultaneous estimation of L-lysine hydrochloride and L-carnitine-L-tartrate in pharmaceutical dosage form.
Qadir MA, et al.
Indian Journal of Pharmaceutical Sciences, 77(4), 434-434 (2015)
Guntur Fibriansah et al.
Nature communications, 6, 6341-6341 (2015-02-24)
Dengue virus (DENV) infects ~400 million people annually. There is no licensed vaccine or therapeutic drug. Only a small fraction of the total DENV-specific antibodies in a naturally occurring dengue infection consists of highly neutralizing antibodies. Here we show that
Anne M Muskalla et al.
Clinical chemistry, 60(12), 1543-1548 (2014-10-11)
G-protein receptor kinase 4 polymorphism influences blood pressure regulation via modulation of dopamine receptor D1 in renal proximal tubular cells. We investigated the role of G-protein receptor kinase 4 polymorphism in the response to hypertensive therapy in patients with essential
Rick Kapur et al.
British journal of haematology, 166(6), 936-945 (2014-06-10)
Haemolytic disease of the fetus and newborn (HDFN) may occur when maternal IgG antibodies against red blood cells (RBCs), often anti-RhD (anti-D) antibodies, cross the placenta and mediate the destruction of RBCs via phagocytic IgG-Fc-receptors (FcγR). Clinical severity is not
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique